The Journal of Nutritional Biochemistry
Volume 20, Issue 11 , Pages 901-908 , November 2009

Cinnamon extract inhibits the postprandial overproduction of apolipoprotein B48-containing lipoproteins in fructose-fed animals

  • Bolin Qin

      Affiliations

    • Beltsville Human Nutrition Research Center, Agricultural Research Service, U.S. Department of Agriculture, Beltsville, MD 20705, USA
    • Integrity Nutraceuticals International, Spring Hill, TN 37174, USA
    • Corresponding Author InformationCorresponding authors. Bolin Qin is to be contacted at USDA-ARS-BHNRC-DGIL, Beltsville, MD 20705, USA. Tel.: +1 301 504 5253x272; fax: +1 301 504 9062. Richard A. Anderson, Tel.: +1 301 504 8091; fax: +1 301 504 9062.
    • ,
  • Marilyn M. Polansky

      Affiliations

    • Beltsville Human Nutrition Research Center, Agricultural Research Service, U.S. Department of Agriculture, Beltsville, MD 20705, USA
    • ,
  • Yuzo Sato

      Affiliations

    • Department of Health Science, Faculty of Psychological and Physical Science, Aichi Gakuin University, Nisshin 470-0195, Japan
    • ,
  • Khosrow Adeli

      Affiliations

    • Department of Laboratory Medicine and Pathobiology, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada M5G 1X8
    • ,
  • Richard A. Anderson

      Affiliations

    • Beltsville Human Nutrition Research Center, Agricultural Research Service, U.S. Department of Agriculture, Beltsville, MD 20705, USA
    • Corresponding Author InformationCorresponding authors. Bolin Qin is to be contacted at USDA-ARS-BHNRC-DGIL, Beltsville, MD 20705, USA. Tel.: +1 301 504 5253x272; fax: +1 301 504 9062. Richard A. Anderson, Tel.: +1 301 504 8091; fax: +1 301 504 9062.

Received 21 May 2008 ,Revised 13 August 2008 ,Accepted 15 August 2008.

References 

  1. Cohn JS. Postprandial lipemia: emerging evidence for atherogenicity of remnant lipoproteins.. Can J Cardiol. 1998;14(Suppl B):18B–27B
  2. Sniderman AD. Postprandial hypertriglyceridemia(s): time to enlarge our pathophysiologic perspective. Eur J Clin Invest. 2000;30:935–937
  3. Zilversmit DB. Atherogenic nature of triglycerides, postprandial lipidemia, and triglyceride-rich remnant lipoproteins. Clin Chem. 1995;41:153–158
  4. Kolovou GD, Anagnostopoulou KK, Daskalopoulou SS, Mikhailidis DP, Cokkinos DV. Clinical relevance of postprandial lipaemia. Curr Med Chem. 1995;12:1931–1945
  5. Doi H, Kugiyama K, Ohgushi M, Sugiyama S, Matsumura T, Ohta Y, et al. Remnants of chylomicron and very low density lipoprotein impair endothelium-dependent vasorelaxation. Atherosclerosis. 1998;137:341–349
  6. Mero N, Malmstrom R, Steiner G, Taskinen MR, Syvanne M. Postprandial metabolism of apolipoprotein B-48-and B-100-containing particles in type 2 diabetes mellitus: relations to angiographically verified severity of coronary artery disease. Atherosclerosis. 2000;150:167–177
  7. Adeli K, Taghibiglou C, Van Iderstine SC, Lewis GF. Mechanisms of hepatic very low-density lipoprotein overproduction in insulin resistance. Trends Cardiovasc Med. 2001;11:170–176
  8. Carpentier A, Taghibiglou C, Leung N, Szeto L, Van Iderstine SC, Uffelman KD, et al. Ameliorated hepatic insulin resistance is associated with normalization of microsomal triglyceride transfer protein expression and reduction in very low density lipoprotein assembly and secretion in the fructose-fed hamster. J Biol Chem. 2002;277:28795–28802
  9. Haidari M, Leung N, Mahbub F, Uffelman KD, Kohen-Avramoglu R, Lewis GF, et al. Fasting and postprandial overproduction of intestinally derived lipoproteins in an animal model of insulin resistance. Evidence that chronic fructose feeding in the hamster is accompanied by enhanced intestinal de novo lipogenesis and ApoB48-containing lipoprotein overproduction. J Biol Chem. 2002;277:31646–31655
  10. Lewis GF, Naples M, Uffelman K, Leung N, Szeto L, Adeli K. Intestinal lipoprotein production is stimulated by an acute elevation of plasma free fatty acids in the fasting state: studies in insulin-resistant and insulin-sensitized Syrian golden hamsters. Endocrinology. 2004;145:5006–5012
  11. Zoltowska M, Ziv E, Delvin E, Sinnett D, Kalman R, Garofalo C, et al. Cellular aspects of intestinal lipoprotein assembly in Psammomys obesus: a model of insulin resistance and type 2 diabetes. Diabetes. 2003;52:2539–2545
  12. Zheng C, Ikewaki K, Walsh BW, Sacks FM. Metabolism of apoB lipoproteins of intestinal and hepatic origin during constant feeding of small amounts of fat. J Lipid Res. 2006;47:1771–1779
  13. Welty FK, Lichtenstein AH, Barrett PH, Dolnikowski GG, Schaefer EJ. Human apolipoprotein (Apo) B-48 and ApoB-100 kinetics with stable isotopes. Arterioscler Thromb Vasc Biol. 1999;19:2966–2974
  14. Qin B, Nagasaki M, Ren M, Bajotto G, Oshida Y, Sato Y. Cinnamon extract (traditional herb) potentiates in vivo insulin-regulated glucose utilization via enhancing insulin signaling in rats. Diabetes Res Clin Pract. 2003;62:139–148
  15. Qin B, Nagasaki M, Ren M, Bajotto G, Oshida Y, Sato Y. Cinnamon extract prevents the insulin resistance induced by a high-fructose diet. Horm Metab Res. 2004;36:119–125
  16. Broadhurst CL, Polansky MM, Anderson RA. Insulin-like biological activity of culinary and medicinal plant aqueous extracts in vitro. J Agric Food Chem. 2000;48:849–852
  17. Anderson RA, Broadhurst CL, Polansky MM, Schmidt WF, Khan A, Flanagan VP, et al. Isolation and characterization of polyphenol type-A polymers from cinnamon with insulin-like biological activity. J Agric Food Chem. 2004;52:65–70
  18. Imparl-Radosevich J, Deas S, Polansky MM, Baedke DA, Ingebritsen TS, Anderson RA, et al. Regulation of PTP-1 and insulin receptor kinase by fractions from cinnamon: implications for cinnamon regulation of insulin signalling. Horm Res. 1998;50:177–182
  19. Jarvill-Taylor KJ, Anderson RA, Graves DJ. A hydroxychalcone derived from cinnamon functions as a mimetic for insulin in 3T3-L1 adipocytes. J Am Coll Nutr. 2001;20:327–336
  20. Ziegenfuss TN, Hofheins JE, Mendel RW, Landis J, Anderson RA. Effects of a water-soluble cinnamon extract on body composition and features of the metabolic syndrome in pre-diabetic men and women. J Int Soc Sports Nutr. 2006;3:45–53
  21. Roussel AM, Hininger I, Benaraba R, Ziegenfuss TN, Anderson RA. Antioxidant effects of a cinnamon extract in people with impaired fasting glucose that are overweight or obese.. J Am Coll Nutr. 2008;[in press]
  22. Wang JG, Anderson RA, Graham GM, Chu MC, Sauer MV, Guarnaccia MM, et al. The effect of cinnamon extract on insulin resistance parameters in polycystic ovary syndrome: a pilot study. Fertil Steril. 2007;88:240–243
  23. Mang B, Wolters M, Schmitt B, Kelb K, Lichtinghagen R, Stichtenoth DO, et al. Effects of a cinnamon extract on plasma glucose, HbA, and serum lipids in diabetes mellitus type 2. Eur J Clin Invest. 2006;36:340–344
  24. Khan A, Safdar M, li Khan MM, Khattak KN, Anderson RA. Cinnamon improves glucose and lipids of people with type 2 diabetes. Diabetes Care. 2003;26:3215–3218
  25. Kannappan S, Jayaraman T, Rajasekar P, Ravichandran MK, Anuradha CV. Cinnamon bark extract improves glucose metabolism and lipid profile in the fructose-fed rat. Singapore Med J. 2006;47:858–863
  26. Lee JS, Jeon SM, Park EM, Huh TL, Kwon OS, Lee MK, et al. Cinnamate supplementation enhances hepatic lipid metabolism and antioxidant defense systems in high cholesterol-fed rats. J Med Food. 2003;6:183–191
  27. Subash BP, Prabuseenivasan S, Ignacimuthu S. Cinnamaldehyde — a potential antidiabetic agent. Phytomedicine. 2007;14:15–22
  28. Goulinet S, Chapman MJ. Plasma lipoproteins in the golden Syrian hamster (Mesocricetus auratus): heterogeneity of apoB-and apoA-I-containing particles. J Lipid Res. 1993;34:943–959
  29. Hoang VQ, Pearce NJ, Suckling KE, Botham KM. Evaluation of cultured hamster hepatocytes as an experimental model for the study of very low density lipoprotein secretion. Biochim Biophys Acta. 1995;1254:37–44
  30. Federico LM, Naples M, Taylor D, Adeli K. Intestinal insulin resistance and aberrant production of apolipoprotein B48 lipoproteins in an animal model of insulin resistance and metabolic dyslipidemia: evidence for activation of protein tyrosine phosphatase-1B, extracellular signal-related kinase, and sterol regulatory element-binding protein-1c in the fructose-fed hamster intestine. Diabetes. 2006;55:1316–1326
  31. Qin B, Qiu W, Avramoglu RK, Adeli K. Tumor necrosis factor-alpha induces intestinal insulin resistance and stimulates the overproduction of intestinal apolipoprotein B48-containing lipoproteins. Diabetes. 2007;56:450–461
  32. Wetterau JR, Lin MC, Jamil H. Microsomal triglyceride transfer protein. Biochim Biophys Acta. 1997;1345:136–150
  33. Foufelle F, Ferre P. New perspectives in the regulation of hepatic glycolytic and lipogenic genes by insulin and glucose: a role for the transcription factor sterol regulatory element binding protein-1c. Biochem J. 2002;366:377–391
  34. Arbeeny CM, Meyers DS, Bergquist KE, Gregg RE. Inhibition of fatty acid synthesis decreases very low density lipoprotein secretion in the hamster. J Lipid Res. 1992;33:843–851
  35. Lewis GF, Uffelman K, Naples M, Szeto L, Haidari M, Adeli K. Intestinal lipoprotein overproduction, a newly recognized component of insulin resistance, is ameliorated by the insulin sensitizer rosiglitazone: studies in the fructose-fed Syrian golden hamster. Endocrinology. 2005;146:247–255
  36. Phillips C, Owens D, Collins P, Tomkin GH. Microsomal triglyceride transfer protein: does insulin resistance play a role in the regulation of chylomicron assembly?. Atherosclerosis. 2002;160:355–360
  37. Phillips C, Bennett A, Anderton K, Owens D, Collins P, White D, et al. Intestinal rather than hepatic microsomal triglyceride transfer protein as a cause of postprandial dyslipidemia in diabetes. Metabolism. 2002;51:847–852
  38. Gleeson A, Anderton K, Owens D, Bennett A, Collins P, Johnson A, et al. The role of microsomal triglyceride transfer protein and dietary cholesterol in chylomicron production in diabetes. Diabetologia. 1999;42:944–948
  39. Hagan DL, Kienzle B, Jamil H, Hariharan N. Transcriptional regulation of human and hamster microsomal triglyceride transfer protein genes. Cell type-specific expression and response to metabolic regulators. J Biol Chem. 1994;269:28737–28744
  40. Wang SL, Du EZ, Martin TD, Davis RA. Coordinate regulation of lipogenesis, the assembly and secretion of apolipoprotein B-containing lipoproteins by sterol response element binding protein 1. J Biol Chem. 1997;272:19351–19358
  41. Nagai Y, Nishio Y, Nakamura T, Maegawa H, Kikkawa R, Kashiwagi A. Amelioration of high fructose-induced metabolic derangements by activation of PPARalpha. Am J Physiol Endocrinol Metab. 2002;282:E1180–E1190

☆ This project was supported by a USDA Cooperative Research and Development Agreement (CRADA No. 58-3K95-7-1184) with Integrity, Spring Hill, TN. Bolin Qin is a visiting scientist, working at the USDA/ARS/BHNRC, and is also employed by Integrity.

PII: S0955-2863(08)00190-3

doi: 10.1016/j.jnutbio.2008.08.005

The Journal of Nutritional Biochemistry
Volume 20, Issue 11 , Pages 901-908 , November 2009

Article Tools

* Image Usage & Resolution